These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1983774)

  • 21. Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot study.
    Blanchet PJ; Normandeau L; Rompré PH
    Schizophr Res; 2012 May; 137(1-3):230-3. PubMed ID: 22309978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metoclopramide-induced parkinsonism in hemodialysis patients. Report of two cases.
    Sirota RA; Kimmel PL; Trichtinger MD; Diamond BF; Stein HD; Yudis M
    Arch Intern Med; 1986 Oct; 146(10):2070-1. PubMed ID: 3767555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrapyramidal side effects of antiemetics presenting as psychiatric illness.
    Rodgers C
    Gen Hosp Psychiatry; 1992 May; 14(3):192-5. PubMed ID: 1601295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Other causes of parkinsonism.
    Tison F
    Baillieres Clin Neurol; 1997 Apr; 6(1):205-18. PubMed ID: 9426876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of neuroleptic-induced parkinsonism.
    Hassin-Baer S; Sirota P; Korczyn AD; Treves TA; Epstein B; Shabtai H; Martin T; Litvinjuk Y; Giladi N
    J Neural Transm (Vienna); 2001; 108(11):1299-308. PubMed ID: 11768628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of hyposmia and other non-motor symptoms to distinguish between drug-induced parkinsonism and Parkinson's disease.
    Morley JF; Duda JE
    J Parkinsons Dis; 2014; 4(2):169-73. PubMed ID: 24284418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism.
    Widner H; Tetrud J; Rehncrona S; Snow BJ; Brundin P; Björklund A; Lindvall O; Langston JW
    Adv Neurol; 1993; 60():729-33. PubMed ID: 8420218
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-induced parkinsonism.
    Lancet; 1985 Jan; 1(8420):113. PubMed ID: 2857014
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Severe parkinsonism due to metoclopramide: the importance of early recognition].
    de Ronde MW; Kingma HJ; Munts AG
    Ned Tijdschr Geneeskd; 2013; 157(26):A6037. PubMed ID: 23835236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE; Brown WL; Weigel RM; Casey DE
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis.
    Sadeh M; Goldhammer Y
    Eur Neurol; 1993; 33(1):48-50. PubMed ID: 8440286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature.
    Miller LG; Jankovic J
    Arch Intern Med; 1989 Nov; 149(11):2486-92. PubMed ID: 2684075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metoclopramide-induced parkinsonism.
    Sethi KD; Patel B; Meador KJ
    South Med J; 1989 Dec; 82(12):1581-2. PubMed ID: 2595431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of recognition of drug-induced parkinsonism in the elderly.
    Esper CD; Factor SA
    Mov Disord; 2008 Feb; 23(3):401-4. PubMed ID: 18067180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seborrheic dermatitis in neuroleptic-induced parkinsonism.
    Binder RL; Jonelis FJ
    Arch Dermatol; 1983 Jun; 119(6):473-5. PubMed ID: 6134496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
    Munhoz RP; Bertucci Filho D; Teive HA
    Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.